4.8 Article

Association of Serum Aldosterone and Plasma Renin Activity With Ambulatory Blood Pressure in African Americans The Jackson Heart Study

Journal

CIRCULATION
Volume 143, Issue 24, Pages 2355-2366

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/CIRCULATIONAHA.120.050896

Keywords

African Americans; aldosterone; blood pressure monitoring; ambulatory; hypertension; longitudinal studies

Funding

  1. Jackson State University from the National Heart, Lung, and Blood Institute and the National Institute for Minority Health and Health Disparities [HHSN268201800013I]
  2. Tougaloo College from the National Heart, Lung, and Blood Institute and the National Institute for Minority Health and Health Disparities [HHSN268201800014I]
  3. Mississippi State Department of Health from the National Heart, Lung, and Blood Institute and the National Institute for Minority Health and Health Disparities [HHSN268201800015I/HHSN26800001]
  4. University of Mississippi Medical Center from the National Heart, Lung, and Blood Institute and the National Institute for Minority Health and Health Disparities [HHSN268201800010I, HHSN268201800011I, HHSN268201800012I]
  5. Robert Wood Johnson Foundation (Harold Amos Medical Faculty Development Program) [76236]
  6. National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health [K23 DK117041]
  7. Roessler Research Scholarship through the Ohio State University College of Medicine
  8. American Heart Association [18AFMDP34380732]
  9. National Institutes of Health/National Heart, Lung, and Blood Institute [K23 HL14168201A1]

Ask authors/readers for more resources

The study revealed that suppressed renin activity and higher aldosterone:renin ratios were associated with higher systolic and diastolic blood pressure in various settings. Higher aldosterone levels were linked to higher diastolic blood pressure but not systolic blood pressure in different monitoring periods.
Background: The renin-angiotensin-aldosterone system (RAAS) is an important driver of blood pressure (BP), but the association of the RAAS with ambulatory BP (ABP) and ABP monitoring phenotypes among African Americans has not been assessed. Methods: ABP and ABP monitoring phenotypes were assessed in 912 Jackson Heart Study participants with aldosterone and plasma renin activity (PRA). Multivariable linear and logistic regression analyses were used to analyze the association of aldosterone and PRA with clinic, awake, and asleep systolic BP and diastolic BP (DBP) and ABP monitoring phenotypes, adjusting for important confounders. Results: The mean age of participants was 59 +/- 11 years and 69% were female. In fully adjusted models, lower log-PRA was associated with higher clinic, awake, and asleep systolic BP and DBP (all P<0.05). A higher log-aldosterone was associated with higher clinic, awake, and asleep DBP (all P<0.05). A 1-unit higher log-PRA was associated with lower odds of daytime hypertension (odds ratio [OR] 0.59 [95% CI, 0.49-0.71]), nocturnal hypertension (OR, 0.68 [95% CI, 0.58-0.79]), daytime and nocturnal hypertension (OR, 0.59 [95% CI, 0.48-0.71]), sustained hypertension (OR, 0.52 [95% CI, 0.39-0.70]), and masked hypertension (OR 0.75 [95% CI, 0.62-0.90]). A 1-unit higher log-aldosterone was associated with higher odds of nocturnal hypertension (OR, 1.38 [95% CI, 1.05-1.81]). Neither PRA nor aldosterone was associated with percent dipping, nondipping BP pattern, or white-coat hypertension. Patterns for aldosterone:renin ratio were similar to patterns for PRA. Conclusions: Suppressed renin activity and higher aldosterone:renin ratios were associated with higher systolic BP and DBP in the office and during the awake and asleep periods as evidenced by ABP monitoring. Higher aldosterone levels were associated with higher DBP, but not systolic BP, in the clinic and during the awake and asleep periods. Further clinical investigation of novel and approved medications that target low renin physiology such as epithelial sodium channel inhibitors and mineralocorticoid receptor antagonists may be paramount in improving hypertension control in African Americans.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available